Juhl CB - Search Results

1

Juhl CB, Bradley U, Holst JJ, Leslie RD, Yderstraede KB, Hunter S; Action LADA Consortium. Juhl CB, et al. Diabet Med. 2014 Aug;31(8):941-5. doi: 10.1111/dme.12434. Epub 2014 Apr 9. Diabet Med. 2014. PMID: 24628669

2

Short-term treatment with GLP-1 increases pulsatile insulin secretion in Type II diabetes with no effect on orderliness.

Juhl CB, Schmitz O, Pincus S, Holst JJ, Veldhuis J, Pørksen N. Juhl CB, et al. Diabetologia. 2000 May;43(5):583-8. doi: 10.1007/s001250051347. Diabetologia. 2000. PMID: 10855533 Clinical Trial.

3

Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance.

Ritzel R, Schulte M, Pørksen N, Nauck MS, Holst JJ, Juhl C, März W, Schmitz O, Schmiegel WH, Nauck MA. Ritzel R, et al. Diabetes. 2001 Apr;50(4):776-84. doi: 10.2337/diabetes.50.4.776. Diabetes. 2001. PMID: 11289042 Clinical Trial.

4

Repaglinide treatment amplifies first-phase insulin secretion and high-frequency pulsatile insulin release in Type 2 diabetes.

Hollingdal M, Sturis J, Gall MA, Damsbo P, Pincus S, Veldhuis JD, Pørksen N, Schmitz O, Juhl CB. Hollingdal M, et al. Among authors: juhl cb. Diabet Med. 2005 Oct;22(10):1408-13. doi: 10.1111/j.1464-5491.2005.01652.x. Diabet Med. 2005. PMID: 16176204 Clinical Trial.

5

Automated detection of hypoglycemia-induced EEG changes recorded by subcutaneous electrodes in subjects with type 1 diabetes--the brain as a biosensor.

Juhl CB, Højlund K, Elsborg R, Poulsen MK, Selmar PE, Holst JJ, Christiansen C, Beck-Nielsen H. Juhl CB, et al. Diabetes Res Clin Pract. 2010 Apr;88(1):22-8. doi: 10.1016/j.diabres.2010.01.007. Epub 2010 Jan 15. Diabetes Res Clin Pract. 2010. PMID: 20074827 Clinical Trial.

6

Delayed β-cell response and glucose intolerance in young women with Turner syndrome.

Hjerrild BE, Holst JJ, Juhl CB, Christiansen JS, Schmitz O, Gravholt CH. Hjerrild BE, et al. Among authors: juhl cb. BMC Endocr Disord. 2011 Mar 15;11:6. doi: 10.1186/1472-6823-11-6. BMC Endocr Disord. 2011. PMID: 21406078 Free PMC article.

7

Calcineurin inhibitors acutely improve insulin sensitivity without affecting insulin secretion in healthy human volunteers.

Øzbay LA, Møller N, Juhl C, Bjerre M, Carstens J, Rungby J, Jørgensen KA. Øzbay LA, et al. Br J Clin Pharmacol. 2012 Apr;73(4):536-45. doi: 10.1111/j.1365-2125.2011.04118.x. Br J Clin Pharmacol. 2012. PMID: 21988494 Free PMC article. Clinical Trial.

8

Increased action of pulsatile compared to non-pulsatile insulin delivery during a meal-like glucose exposure simulated by computerized infusion in healthy humans.

Juhl CB, Gjedsted J, Nielsen MF, Schmitz O. Juhl CB, et al. Metabolism. 2012 Aug;61(8):1177-81. doi: 10.1016/j.metabol.2011.12.014. Epub 2012 Mar 3. Metabolism. 2012. PMID: 22386942

9

The impact of calcineurin inhibitors on insulin sensitivity and insulin secretion: a randomized crossover trial in uraemic patients.

Ozbay LA, Møller N, Juhl C, Bjerre M, Carstens J, Rungby J, Jørgensen KA. Ozbay LA, et al. Diabet Med. 2012 Dec;29(12):e440-4. doi: 10.1111/dme.12028. Diabet Med. 2012. PMID: 23003106 Clinical Trial.

10

Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency - a double-blind, randomized, placebo-controlled trial.

Kampmann U, Mosekilde L, Juhl C, Moller N, Christensen B, Rejnmark L, Wamberg L, Orskov L. Kampmann U, et al. Metabolism. 2014 Sep;63(9):1115-24. doi: 10.1016/j.metabol.2014.06.008. Epub 2014 Jun 19. Metabolism. 2014. PMID: 25044176 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

213 results

Search Page